Antiviral therapy for hepatitis C in the setting of liver transplantation
β Scribed by Gregory T. Everson; Clark C. Kulig
- Book ID
- 107558401
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 574 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1092-8472
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Hepatitis C infection following orthotopic liver transplantation may lead to progressive chronic graft dysfunction. In this study, seven liver transplant recipients with chronic allograft dysfunction due to hepatitis C infection (one acquired and six recurrent infections) were treated with oral riba
Posttransplantation recurrence of hepatitis C virus infection is a universal phenomenon with a highly variable natural history. 2. Approximately 10% to 25% of hepatitis C virusinfected recipients of liver allografts will develop cirrhosis within 5 years' after transplantation. 3. The 1-year actuaria
Adherence to antiviral therapy is essential to achieve sustained virological responses in patients treated for hepatitis C. An important limitation to use of appropriate doses of ribavirin is development of anemia. The aim of this study is to identify risk factors associated with anemia in liver tra